62 related articles for article (PubMed ID: 32442760)
1. Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples.
Scribano S; Guerrini M; Arvia R; Guasti D; Nardini P; Romagnoli P; Giannecchini S
J Clin Virol; 2020 Jul; 128():104435. PubMed ID: 32442760
[TBL] [Abstract][Full Text] [Related]
2. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V
Virol J; 2013 Sep; 10():298. PubMed ID: 24079660
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles.
Oberholster L; Mathias A; Perriot S; Blaser E; Canales M; Jones S; Culebras L; Gimenez M; Kaynor GC; Sapozhnik A; Richetin K; Goelz S; Du Pasquier R
Microbiol Spectr; 2023 Dec; 11(6):e0275123. PubMed ID: 37815349
[TBL] [Abstract][Full Text] [Related]
4. JC Virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor.
O'Hara BA; Morris-Love J; Gee GV; Haley SA; Atwood WJ
PLoS Pathog; 2020 Mar; 16(3):e1008371. PubMed ID: 32130281
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9.
Chou YY; Krupp A; Kaynor C; Gaudin R; Ma M; Cahir-McFarland E; Kirchhausen T
Sci Rep; 2016 Nov; 6():36921. PubMed ID: 27841295
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of highly pathogenic strains of human JC polyomavirus in neurological patients by next generation sequencing.
Auvinen E; Honkimaa A; Laine P; Passerini S; Moens U; Pietropaolo V; Saarela M; Maunula L; Mannonen L; Tynninen O; Haapasalo H; Rauramaa T; Auvinen P; Liimatainen H
J Clin Virol; 2024 Apr; 171():105652. PubMed ID: 38364704
[TBL] [Abstract][Full Text] [Related]
7. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
Prezioso C; Passerini S; Limongi D; Palamara AT; Moens U; Pietropaolo V
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146876
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19: a case report.
Lv Y; Liu X
BMC Urol; 2024 Apr; 24(1):87. PubMed ID: 38627797
[TBL] [Abstract][Full Text] [Related]
9. Co-Detection of EBV and Human Polyomavirus JCPyV in a Case of AIDS-Related Multifocal Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
Barbier MT; Del Valle L
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992464
[TBL] [Abstract][Full Text] [Related]
10. An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy.
Kaiserman J; O'Hara BA; Haley SA; Atwood WJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239927
[TBL] [Abstract][Full Text] [Related]
11. High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond ACS; Crocker MA; Wilczek MP; DuShane JK; Sandberg AL; Bennett LJ; Leclerc NR; Maginnis MS
Antiviral Res; 2024 Feb; 222():105817. PubMed ID: 38246207
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the NKG2D ligand ULBP2 by JC polyomavirus infection promotes immune recognition by natural killer cells.
Jost S; Ahn J; Chen S; Yoder T; Gikundiro KE; Lee E; Gressens SB; Kroll K; Craemer M; Kaynor GC; Lifton M; Tan CS
J Infect Dis; 2023 Sep; ():. PubMed ID: 37774496
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital.
Ligero-López J; Sánchez-Castellano MÁ; Falces-Romero I; Montero-Vega MD; García-Rodríguez J
J Neurovirol; 2023 Oct; 29(5):598-604. PubMed ID: 37470903
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of JC Polyomavirus in Patients with Neuroinvasive Disease of Unknown Etiology in Croatia.
Vilibic-Cavlek T; Bogdanic M; Peric T; Radmanic L; Antolasic L; Milasincic L; Zidovec-Lepej S
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256330
[No Abstract] [Full Text] [Related]
15. Designing a Multi-Epitope Subunit Vaccine against VP1 Major Coat Protein of JC Polyomavirus.
Kanse S; Khandelwal M; Pandey RK; Khokhar M; Desai N; Kumbhar BV
Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514998
[TBL] [Abstract][Full Text] [Related]
16. Case report: JC polyomavirus nephropathy in simultaneous heart-kidney transplantation: the role of viral-specific
Abu Jawdeh BG; Smith ML; Hudson MR; Mour GK; Budhiraja P; Rosenthal JL
Front Med (Lausanne); 2023; 10():1282827. PubMed ID: 37928458
[TBL] [Abstract][Full Text] [Related]
17. Orderly Steps in Progression of JC Virus to Virulence in the Brain.
Johnson EM; Wortman MJ; Lundberg PS; Daniel DC
Brain Disord Ther; 2015 Aug; 4(Suppl 2):. PubMed ID: 27274953
[TBL] [Abstract][Full Text] [Related]
18. Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV.
Johnston CD; de Menezes EGM; Bowler S; Siegler EL; Friday C; Norris PJ; Rice MC; Choi ME; Glesby MJ; Ndhlovu LC
J Neurovirol; 2023 Apr; 29(2):225. PubMed ID: 37005979
[No Abstract] [Full Text] [Related]
19. Polyomavirus Wakes Up and Chooses Neurovirulence.
Butic AB; Spencer SA; Shaheen SK; Lukacher AE
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896889
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
